Changes of hematological and immunological parameters in COVID-19 patients

Springer Science and Business Media LLC - Tập 112 Số 4 - Trang 553-559 - 2020
Xiaohong Yuan1, Wei-Chao Huang1, Bing Yan2, Cunrong Chen2, Rongfeng Huang3, Feng Wu4, Wei Qin5, Wei Zhang5, Jianda Hu1
1Fujian Insitute of Hematology, Fujian Medical University Union Hospital, No. 29, Xinquan Road, Gulou District, Fuzhou, Fujian, China
2Department of Critical Care Medicine, Fujian Medical University Union Hospital, Fuzhou, Fujian, China
3Department of Gastrby Nterology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China
4Department of Respiratory Medicine, Fujian Medical University Union Hospital, Fuzhou, Fujian, China
5Department of Hospital Administration Office, Fujian Medical University Union Hospital, No. 29, Xinquan Road, Gulou District, Fuzhou, Fujian, China

Tóm tắt

Từ khóa


Tài liệu tham khảo

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2002032.

Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. Severe acute respiratory syndrome related coronavirus: the species and its—viruses a statement of the Coronavirus Study Group. bioRxiv. 2020. https://doi.org/10.1101/2020.02.07.937862.

Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–3. https://doi.org/10.1038/s41586-020-2012-7.

Rabaan AA, Al-Ahmed SH, Haque S, Sah R, Tiwari R, Malik YS, et al. SARS-CoV-2, SARS-CoV, and MERS-COV: a comparative overview. Le infezioni in medicina. 2020;28(2):174–84.

Novel coronavirus infected pneumonia treatment scheme—Sixth edition. National Health Commission of the People's Republic of China. 2020. https://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml. Accessed 19 Feb 2020

Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S, et al. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J Med Virol. 2020. https://doi.org/10.1002/jmv.25727.

Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260–3. https://doi.org/10.1126/science.abb2507.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020. https://doi.org/10.1001/jama.2020.1585.

Zhu Y, Cao X, Tao G, Xie W, Hu Z, Xu D. The lymph index: a potential hematological parameter for viral infection. Int J Infect Dis. 2013;17(7):e490–e493493. https://doi.org/10.1016/j.ijid.2012.12.002.

Al-Tawfiq JA, Hinedi K, Abbasi S, Babiker M, Sunji A, Eltigani M. Hematologic, hepatic, and renal function changes in hospitalized patients with Middle East respiratory syndrome coronavirus. Int J Lab Hematol. 2017;39(3):272–8. https://doi.org/10.1111/ijlh.12620.

Panesar NS. What caused lymphopenia in SARS and how reliable is the lymphokine status in glucocorticoid-treated patients? Med Hypotheses. 2008;71(2):298–301. https://doi.org/10.1016/j.mehy.2008.03.019.

He Z, Zhao C, Dong Q, Zhuang H, Song S, Peng G, et al. Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets. Int J Infect Dis. 2005;9(6):323–30. https://doi.org/10.1016/j.ijid.2004.07.014.

Chu H, Zhou J, Wong BH, Li C, Chan JF, Cheng ZS, et al. Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J Infect Dis. 2016;213(6):904–14. https://doi.org/10.1093/infdis/jiv380.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–2. https://doi.org/10.1016/s2213-2600(20)30076-x.

Prilutskiy A, Kritselis M, Shevtsov A, Yambayev I, Vadlamudi C, Zhao Q, et al. SARS-CoV-2 infection associated hemophagocytic lymphohistiocytosis: an autopsy series with clinical and laboratory correlation. medRxiv. 2020. https://doi.org/10.1101/2020.05.07.20094888.

Chousterman BG, Swirski FK, Weber GF. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 2017;39(5):517–28. https://doi.org/10.1007/s00281-017-0639-8.

Radbel J, Narayanan N, Bhatt PJ. Use of tocilizumab for COVID-19 infection-induced cytokine release syndrome: a cautionary case report. Chest. 2020. https://doi.org/10.1016/j.chest.2020.04.024.

Zhang S, Li L, Shen A, Chen Y, Qi Z. Rational use of tocilizumab in the treatment of novel coronavirus pneumonia. Clin Drug Investig. 2020. https://doi.org/10.1007/s40261-020-00917-3.

Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–7. https://doi.org/10.1111/jth.14768.

Dolhnikoff M, Duarte-Neto AN, de Almeida Monteiro RA, da Ferraz Silva LF, de PierreOliveira E, Nascimento Saldiva PH, et al. Pathological evidence of pulmonary thrombotic phenomena in severe. J Thromb Haemost. 2020. https://doi.org/10.1111/jth.14844.

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Tập 112 Số 4

553-559

Thông tin tác giả